Proceedings of the International Conference on Health and Well-Being (ICHWB 2022)

The Effect of Odontoblast Formation on Reversible Pulpitis After Application of Calcium Hydroxide and Mineral Trioxide Aggregate: Literature Review

Authors
Elly Lintang Sonia1, *, Cahyani Cahyani2
1Faculty of Dentistry, Universitas Muhammadiyah Surakarta (UMS), Surakarta, Indonesia
2Universitas Muhammadiyah Surakarta (UMS), Surakarta, Indonesia
*Corresponding author. Email: ellylintang1998@gmail.com
Corresponding Author
Elly Lintang Sonia
Available Online 30 May 2023.
DOI
10.2991/978-94-6463-184-5_7How to use a DOI?
Keywords
Reversible pulpitis; Odontoblast; Calcium Hydroxide; Mineral Trioxideaggregate (MTA)
Abstract

Reversible pulpitis is a mild to moderate inflammatory condition of the pulp caused by a stimulus, and when the stimulus is removed, the pulp returns to normal. Reversible pulpitis can be caused by several factors, such as dental caries, thermal stimulation, chemical stimulation, and mechanical trauma during cavity preparation. Pulp capping is used to treat reversible pulpitis, which aims to protect the dental pulp by applying medicaments directly to the pulp, which functions to maintain pulp vitality and stimulate the formation of dentinal bridges. Pulp capping treatment is divided into 2 types, namely direct pulp capping performed on exposed pulp that has perforated due to iatrogenic factors, and indirect pulp capping performed on pulp that is not exposed and still has a thin layer of dentin. Calcium Hydroxide and Mineral Trioxideaggregate (MTA) are two commonly used medications that are directly applied to the pulp tissue. The main goal of pulp cap treatment is the formation of reparative dentin, which is formed from odontoblast cells and other pulp cells that indicate a reparative response of the pulp tissue. Odontoblast-like cells are produced from undifferential mesenchyme cells after death. The purpose of this paper is to determine the differences in the formation of odontoblasts in reversible pulpitis cases using Calcium Hydroxide and Mineral Trioxideaggregate (MTA) medicaments. This paper concludes that the two pulp capping medicaments can stimulate the formation of odontoblast cells with Mineral Trioxide Aggregate (MTA) has the best rate of formation speed, followed by Calcium Hydroxide.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the International Conference on Health and Well-Being (ICHWB 2022)
Series
Advances in Health Sciences Research
Publication Date
30 May 2023
ISBN
10.2991/978-94-6463-184-5_7
ISSN
2468-5739
DOI
10.2991/978-94-6463-184-5_7How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Elly Lintang Sonia
AU  - Cahyani Cahyani
PY  - 2023
DA  - 2023/05/30
TI  - The Effect of Odontoblast Formation on Reversible Pulpitis After Application of Calcium Hydroxide and Mineral Trioxide Aggregate: Literature Review
BT  - Proceedings of the International Conference on Health and Well-Being (ICHWB 2022)
PB  - Atlantis Press
SP  - 56
EP  - 66
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-184-5_7
DO  - 10.2991/978-94-6463-184-5_7
ID  - Sonia2023
ER  -